Literature DB >> 22293115

MicroRNA-125b induces cancer cell apoptosis through suppression of Bcl-2 expression.

Aihua Zhao1, Quan Zeng, Xiaoyan Xie, Junnian Zhou, Wen Yue, Yali Li, Xuetao Pei.   

Abstract

MicroRNAs (miRNAs) are small, noncoding RNAs which can often act as an oncogene or a tumor suppressor. Several miRNAs are associated with the development of hepatocellular carcinoma (HCC). We demonstrated that miR-125b significantly suppresses HCC cell proliferation and promotes apoptosis by inhibiting the gene expression of the anti-apoptotic protein, Bcl-2. Bioinformatic analysis indicated that the 3'UTR of Bcl-2 has binding sites for miR-125b. Luciferase reporter assay confirmed the ability of miR-125b to dramatically suppress Bcl-2 transcription, suggesting that Bcl-2 is a target gene for miR-125b. We concluded that miR-125b acts as a tumor suppressor in hepatic tumor development by targeting Bcl-2 and inducing cancer cell apoptosis.
Copyright © 2012. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22293115     DOI: 10.1016/j.jgg.2011.12.003

Source DB:  PubMed          Journal:  J Genet Genomics        ISSN: 1673-8527            Impact factor:   4.275


  49 in total

1.  Function and clinical potential of microRNAs in hepatocellular carcinoma.

Authors:  Lijuan Wang; Yongfang Yue; Xian Wang; Hongchuan Jin
Journal:  Oncol Lett       Date:  2015-09-29       Impact factor: 2.967

Review 2.  Epigenetics of hepatocellular carcinoma: role of microRNA.

Authors:  Sharad Khare; Qiong Zhang; Jamal A Ibdah
Journal:  World J Gastroenterol       Date:  2013-09-07       Impact factor: 5.742

Review 3.  MicroRNAs as biomarkers of cervical cancer development: a literature review on miR-125b and miR-34a.

Authors:  Joana Ribeiro; Hugo Sousa
Journal:  Mol Biol Rep       Date:  2014-01-09       Impact factor: 2.316

4.  MicroRNAs and Glucocorticoid-Induced Apoptosis in Lymphoid Malignancies.

Authors:  Ronit Vogt Sionov
Journal:  ISRN Hematol       Date:  2013-01-29

5.  Downregulation of miR-1266-5P, miR-185-5P and miR-30c-2 in prostatic cancer tissue and cell lines.

Authors:  Shiva Ostadrahimi; Shima Fayaz; Monireh Parvizhamidi; Manuchehr Abedi-Valugerdi; Moustapha Hassan; Mehdi Kadivar; Ladan Teimoori-Toolabi; Mojgan Asgari; Hossein Shahrokh; Maryam Abolhasani; Reza Mahdian; Pezhman Fard-Esfahani
Journal:  Oncol Lett       Date:  2018-03-23       Impact factor: 2.967

6.  HPV-16 E6 promotes cell growth of esophageal cancer via downregulation of miR-125b and activation of Wnt/β-catenin signaling pathway.

Authors:  Bao Zang; Guojin Huang; Xiaowei Wang; Shiying Zheng
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

7.  MicroRNA-200b inhibits pituitary tumor cell proliferation and invasion by targeting PKCα.

Authors:  Yuanchuan Wang; Xiaohong Yin; Long Zhao; Shun Li; Jie Duan; Renzhao Kuang; Junwei Duan
Journal:  Exp Ther Med       Date:  2017-06-27       Impact factor: 2.447

8.  Epigenetics and miRNA as predictive markers and targets for lung cancer chemotherapy.

Authors:  Raafat A El-Awady; Fatema Hersi; Hala Al-Tunaiji; Ekram M Saleh; Abdel-Hady A Abdel-Wahab; Amer Al Homssi; Mousa Suhail; Ahmed El-Serafi; Taleb Al-Tel
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

9.  Prognostic marker microRNA-125b inhibits tumorigenic properties of hepatocellular carcinoma cells via suppressing tumorigenic molecule eIF5A2.

Authors:  Felice H Tsang; Victor Au; Wen-Jing Lu; Felix H Shek; Angela M Liu; John M Luk; Sheung-Tat Fan; Ronnie T P Poon; Nikki P Lee
Journal:  Dig Dis Sci       Date:  2014-05-09       Impact factor: 3.199

10.  Microvesicle microRNA profiles and functional roles between chronic hepatitis B and hepatocellular carcinoma.

Authors:  H Li; L Sun; X Chen; W Xiong; D Hu; S Jie
Journal:  Clin Transl Oncol       Date:  2013-07-18       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.